Literature DB >> 23630251

Structure-kinetic relationship study of CDK8/CycC specific compounds.

Elisabeth V Schneider1, Jark Böttcher, Robert Huber, Klaus Maskos, Lars Neumann.   

Abstract

In contrast with the very well explored concept of structure-activity relationship, similar studies are missing for the dependency between binding kinetics and compound structure of a protein ligand complex, the structure-kinetic relationship. Here, we present a structure-kinetic relationship study of the cyclin-dependent kinase 8 (CDK8)/cyclin C (CycC) complex. The scaffold moiety of the compounds is anchored in the kinase deep pocket and extended with diverse functional groups toward the hinge region and the front pocket. These variations can cause the compounds to change from fast to slow binding kinetics, resulting in an improved residence time. The flip of the DFG motif ("DMG" in CDK8) to the inactive DFG-out conformation appears to have relatively little influence on the velocity of binding. Hydrogen bonding with the kinase hinge region contributes to the residence time but has less impact than hydrophobic complementarities within the kinase front pocket.

Entities:  

Keywords:  kinetic profiling; structure-based drug design

Mesh:

Substances:

Year:  2013        PMID: 23630251      PMCID: PMC3657768          DOI: 10.1073/pnas.1305378110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II.

Authors:  Reena Pinhero; Peter Liaw; Kimberly Bertens; Krassimir Yankulov
Journal:  Eur J Biochem       Date:  2004-03

2.  Kinetic efficiency: the missing metric for enhancing compound quality?

Authors:  Geoffrey A Holdgate; Adrian L Gill
Journal:  Drug Discov Today       Date:  2011-09-10       Impact factor: 7.851

3.  CDK8 is a stimulus-specific positive coregulator of p53 target genes.

Authors:  Aaron Joseph Donner; Stephanie Szostek; Jennifer Michelle Hoover; Joaquin Maximiliano Espinosa
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

4.  Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.

Authors:  Jeffrey R Simard; Matthäus Getlik; Christian Grütter; Vijaykumar Pawar; Sabine Wulfert; Matthias Rabiller; Daniel Rauh
Journal:  J Am Chem Soc       Date:  2009-09-23       Impact factor: 15.419

Review 5.  Structural dissection of cyclin dependent kinases regulation and protein recognition properties.

Authors:  Graziano Lolli
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

6.  Halogen bonds form the basis for selective P-TEFb inhibition by DRB.

Authors:  Sonja Baumli; Jane A Endicott; Louise N Johnson
Journal:  Chem Biol       Date:  2010-09-24

7.  Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.

Authors:  Rachel R Kroe; John Regan; Al Proto; Gregory W Peet; Tapon Roy; Laura D Landro; Natalie G Fuschetto; Christopher A Pargellis; Richard H Ingraham
Journal:  J Med Chem       Date:  2003-10-23       Impact factor: 7.446

8.  Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.

Authors:  Song-Bing He; Yin Yuan; Lei Wang; Min-Jing Yu; Yi-Bei Zhu; Xing-Guo Zhu
Journal:  J Exp Clin Cancer Res       Date:  2011-11-22

9.  Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796).

Authors:  John Regan; Alison Capolino; Pier F Cirillo; Thomas Gilmore; Anne G Graham; Eugene Hickey; Rachel R Kroe; Jeffrey Madwed; Monica Moriak; Richard Nelson; Christopher A Pargellis; Alan Swinamer; Carol Torcellini; Michele Tsang; Neil Moss
Journal:  J Med Chem       Date:  2003-10-23       Impact factor: 7.446

10.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

Authors:  Christopher Pargellis; Liang Tong; Laurie Churchill; Pier F Cirillo; Thomas Gilmore; Anne G Graham; Peter M Grob; Eugene R Hickey; Neil Moss; Susan Pav; John Regan
Journal:  Nat Struct Biol       Date:  2002-04
View more
  31 in total

Review 1.  The drug-target residence time model: a 10-year retrospective.

Authors:  Robert A Copeland
Journal:  Nat Rev Drug Discov       Date:  2015-12-18       Impact factor: 84.694

2.  Rapid and Label-Free Strategy to Isolate Aptamers for Metal Ions.

Authors:  Hao Qu; Andrew T Csordas; Jinpeng Wang; Seung Soo Oh; Michael S Eisenstein; Hyongsok Tom Soh
Journal:  ACS Nano       Date:  2016-07-11       Impact factor: 15.881

3.  A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.

Authors:  Timothy Cholko; Wei Chen; Zhiye Tang; Chia-En A Chang
Journal:  J Comput Aided Mol Des       Date:  2018-05-08       Impact factor: 3.686

4.  Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool.

Authors:  Wei Chen; Xiaodong Ren; Chia-En A Chang
Journal:  ChemMedChem       Date:  2018-12-10       Impact factor: 3.466

5.  A precisely positioned MED12 activation helix stimulates CDK8 kinase activity.

Authors:  Felix Klatt; Alexander Leitner; Iana V Kim; Hung Ho-Xuan; Elisabeth V Schneider; Franziska Langhammer; Robin Weinmann; Melanie R Müller; Robert Huber; Gunter Meister; Claus-D Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-27       Impact factor: 11.205

6.  Structure-guided residence time optimization of a dabigatran reversal agent.

Authors:  Felix Schiele; Joanne van Ryn; Tobias Litzenburger; Michael Ritter; Daniel Seeliger; Herbert Nar
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  All-atomic molecular dynamic studies of human CDK8: insight into the A-loop, point mutations and binding with its partner CycC.

Authors:  Wu Xu; Benjamin Amire-Brahimi; Xiao-Jun Xie; Liying Huang; Jun-Yuan Ji
Journal:  Comput Biol Chem       Date:  2014-04-03       Impact factor: 2.877

8.  Binding Thermodynamics and Kinetics Calculations Using Chemical Host and Guest: A Comprehensive Picture of Molecular Recognition.

Authors:  Zhiye Tang; Chia-En A Chang
Journal:  J Chem Theory Comput       Date:  2017-12-14       Impact factor: 6.006

9.  Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization.

Authors:  Kiyoshi Okamoto; Megumi Ikemori-Kawada; Anja Jestel; Konstanze von König; Yasuhiro Funahashi; Tomohiro Matsushima; Akihiko Tsuruoka; Atsushi Inoue; Junji Matsui
Journal:  ACS Med Chem Lett       Date:  2014-11-17       Impact factor: 4.345

Review 10.  Structure-based discovery of cyclin-dependent protein kinase inhibitors.

Authors:  Mathew P Martin; Jane A Endicott; Martin E M Noble
Journal:  Essays Biochem       Date:  2017-11-08       Impact factor: 8.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.